Login to Your Account



Other News To Note


Monday, April 25, 2011
Inspire Pharmaceuticals Inc., of Raleigh, N.C., postponed its annual stockholders' meeting indefinitely due to its recently disclosed merger agreement with Monarch Transaction Corp., a subsidiary of Whitehouse Station, N.J.-based Merck & Co. Inc. The deal values Inspire at $5 per share, or about $430 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription